Trial intelligence / Profile preview

PLATEFUN: Eltrombopag in cAITP

NCT00888901Phase 4Completed

Sponsor
Ingrid Pabinger
Start
May 2009
Primary completion
Mar 2011
Modality
Small Molecules
01

Overview

A Phase 4 trial of eltrombopag in Chronic Immune Thrombocytopenia (cITP), sponsored by Ingrid Pabinger. Started May 2009; status: completed.

02

Drugs

eltrombopag
03

Conditions

Chronic Immune Thrombocytopenia (cITP)

Beyond the preview

Go deeper on NCT00888901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00888901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call